Efficacy and safety of off-label use of rituximab in refractory lupus: data from the Italian Multicentre Registry. - Concepedia

Concepedia

Publication | Closed Access

Efficacy and safety of off-label use of rituximab in refractory lupus: data from the Italian Multicentre Registry.

109

Citations

0

References

2015

Year

Luca Iaccarino, Elena Bartoloni, Linda Carli, Fulvia Ceccarelli, Fabrizio Conti, Salvatore De Vita, Gianfranco Ferraccioli, Mauro Galeazzi, Mariele Gatto, Roberto Gerli,

Abstract

Data from Italian multicentre RTX Registry confirmed the efficacy and safety of RTX in SLE patients refractory to standard treatment in clinical practice setting.